Close

Current Research in Nutrition and Food Science - An open access, peer reviewed international journal covering all aspects of Nutrition and Food Science

lock and key

Sign in to your account.

Account Login

Forgot your password?

The Association of Cholesterol Transport ABCG1 Polymorphism towards the Susceptibility of Metabolic Syndrome risk factor in Thai Adolescents

Lisandra Maria G.B. Sidabutar, Tippawan Pongcharoen, Uthaiwan Suttisansanee, Nattira On-Nom, Phennapha Luealai, Chanakan Khemthong and Chaowanee Chupeerach*

Institute of Nutrition, Mahidol University, Phutthamonthon, Salaya, Phutthamonthon, Nakhon Pathom, Thailand.

Corresponding Author Email: chaowanee.chu@mahidol.ac.th

DOI : https://dx.doi.org/10.12944/CRNFSJ.10.2.8

Article Publishing History

Received: 23 Feb 2022

Accepted: 21 Jul 2022

Published Online: 27 Jul 2022

Plagiarism Check: Yes

Reviewed by: Rosa María Oliart Ros México

Second Review by: Mohamed Nader
Egypt.

Final Approval by: Dr. Neha Sanwalka

Article Metrics

Views  

PDF Download  PDF Downloads: 549
Abstract:

Asian countries now suffers from a double burden issue that involves metabolic syndrome (MetS) even in the adolescent age. Many factors have been considered to explain this situation including genetic variation contribution to the susceptibility of said metabolic syndrome. ATP-Binding Cassette G1 (ABCG1) is known in its role in cholesterol efflux that is strongly related in lipid accumulation and insulin performance. In addition to this gene modulation work in reverse cholesterol transport that is also connected with the occurrence of metabolic syndrome. However, the effect of polymorphism in rs1044317 remains unclear. A total of 434 subjects in adolescent age were genotyped for ABCG1 rs1044317 by restricted fragmented length polymorphism polymerase chain reaction method. All the anthropometric and laboratory date was extracted by an approved protocol. The correlation of each variables was detected using SPSS ver.21. Frequencies of alleles and genotypes of the ABCG1 polymorphism were similar in both sexes. A significant correlation detected between adjusted males’ group with an increased level of interleukin-6 in wide genotype and an increased fasting blood sugar level in adjusted females’ group in variant genotype. The existence of rs1044317 ABCG1 SNP affected the susceptibility of specific criteria of MetS in Thai adolescence population. Additionally, there is a gender difference in the incidence of MetS, indicating a possible gene–gender interaction of the ABCG1 polymorphism in MetS among Thai adolescents.

Keywords:

ABCG1; Adolescent; Genetic Polymorphism; Interleukin-6; Metabolic Syndrome

Download this article as: 

Copy the following to cite this article:

Sidabutar L. M. G. B, Pongcharoen T, Suttisansanee U, On-Nom N, Luealai P, Khemthong C, Chupeerach C. The Association of Cholesterol Transport ABCG1 Polymorphism towards the Susceptibility of Metabolic Syndrome risk factor in Thai Adolescents. Curr Res Nutr Food Sci 2022; 10(2). doi : http://dx.doi.org/10.12944/CRNFSJ.10.2.8


Copy the following to cite this URL:

Sidabutar L. M. G. B, Pongcharoen T, Suttisansanee U, On-Nom N, Luealai P, Khemthong C, Chupeerach C. The Association of Cholesterol Transport ABCG1 Polymorphism towards the Susceptibility of Metabolic Syndrome risk factor in Thai Adolescents. Curr Res Nutr Food Sci 2022; 10(2). Available From: https://bit.ly/3cII5Nk


Background

Metabolic syndrome (MetS) is now spreading across the nation, including Asian countries and Thailand.1,2 This problem not only affects adulthood but the sign of MetS has been shown since childhood. This condition may lead to many non-communicable diseases like cardiovascular disease, diabetes, and many others as they are getting older. The prevalence of diabetes in the adult population in Thailand is more than 8% in both male and female groups, and the prevalence of metabolic syndrome in children population, based on cross-sectional research done in 2014, was around 4%.3 Originally, MetS in children was defined as a direct consequence of childhood obesity. However, cardio-metabolic (CM) risk traits such as high blood pressure, hyperglycemia, dyslipidemia, and low grade inflammatory are now common in children even in the absence of obesity.4 Furthermore, ethnic variations occur in the distribution of CM risk in children.5 Therefore, the genetic component is also substantial evidence contributing to the susceptibility of MetS.6

ATP-Binding Cassette G1 (ABCG1), a member of the large family of ABC transporters, is known involves in lipid homeostasis and accumulation especially shown in some SNP (Single Nucleotides Polymorphism) of this gene.7,8 Recently, there is a growing body of evidence suggesting that modulation of ABCG1 expression might be contributed to the development of obesity and lead to a high potency of diabetes based on conducted animal study.9,10 Due to those findings, the author considers ABCG1 and its polymorphism might contribute to the susceptibility and development of MetS. Even though there were some studies about 3’UTR single nucleotide polymorphism (SNP) ABCG1 rs1044317 yet the result remained unclear and incoherent.11

In this study, we examined if there is a correlation between the existences of ABCG1 polymorphism (rs1044317) with the MetS or cardio-metabolic risk factors in Thai adolescents. Blood biochemistries such as total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-c), blood glucose and inflammatory marker was taken as the marker in the development of MetS since it supports the theory where excess adiposity participate in MetS and insulin resistance, which has been associated with a pro-inflammatory state.12-14

Materials and Methods

Study Subjects

This cross-sectional study consists of 434 subjects which were the participant of the “Association of early life exposures and long-term health and cognitive development outcomes in adolescents in northeast, Thailand” project, a community-based study that was performed in the adolescence of Khong Kaen province at age around 14 to 16 years old (2013). This study used the DNA samples and data which was stared from 2020. This study was approved from the research ethic committee of human research internal review board, Mahidol University (MU-CIRB) was received the approval this study protocol (MU-CRIB 2016/020.1708).

Anthropometry and Clinical Measurements

Weight, height, and waist circumference were the attained data for anthropometry measurement. Weight was measured with a standardized digital scale (Seca digital scale model 813, Seca Corporation, Hamburg, Germany) and height was measured with measuring tape on the millimeter scale. The weight and height of each participant were calculated with the same method as adults. The waist circumference was measured with inelastic tape in millimeter. Each participant was asked to sit on the chair to measure blood pressure using an automatic blood pressure monitor.

Laboratory Analysis

Fasting blood sugar (FBS), serum triglyceride (TG), total cholesterol (TC), high density lipoprotein cholesterol (HDL) levels were analyzed directly by enzymatic assay. Indirectly, the low-density lipoprotein cholesterol (LDL) levels were calculated using the Friedewald formula.15 Hemoglobin A1 C (HbA1C) level was measured by the high-performance liquid chromatography (HPLC) technique. The inflammatory markers, interleukin-6 (IL-6), and Tumor Necrotic Factor alpha (TNF-  were analyzed using Enzyme-Linked Immunosorbent Assay (ELISA) method based on the suggested method from another study.16 For high sensitivity c- reactive protein (hs-CRP), it was analyzed using the immunoturbidity method according to laboratory procedures.

Metabolic syndrome (MetS) criteria in adolescents  

In the present study, the criteria were adapted from IDF (2015) that released 5 criteria of MetS for adolescence. An adolescent (10-16 years old) can be categorized in MetS when they have following cardio-metabolic risk factors; waist circumference (WC) ≥90th percentile and followed by 2 of 4 other criterias (triglycerides (TG level ≥150mg/dL, high-density lipoprotein cholesterol (HDL) < 40mg/dL, blood pressure (BP) systolic ≥130/ diastolic ≥85 mmHg and fasting blood sugar (FBS) ≥ 100 mg/dL.17,18

Genotyping

Genomic DNA samples were extracted from thawed peripheral leukocytes in EDTA-treated blood using the FlexiGene DNA kit (Qiagen, Hilden, Germany). The ABCG1 gene contained SNP rs1044317 was studied using polymorphism chain reaction-restricted fragment length polymorphism (PCR-RFLP) with these determined primers: Forward: 5’- GCTGGGTTGGATCTTCTCTCC -3’ and Reverse: 5’ – TGGCTTGCAAAAATGACTTCTCA   -3’. The temperature conditions for the polymerase chain reaction (PCR) were set at 94°C with 5 minutes for initial denaturation, 32 cycles at 94°C for denaturation, 51°C for annealing, and 72°C for extension, each step lasting 45 s, with a final extension for 5 min, at 72°C. The amplification products yielded a 359-base pair (bp) fragment, of which the A allele contained a HhaI site (234/125 bp). PCR products underwent enzymatic digestion were resolved on 3.0% agarose gel electrophoresis.

Statistical Analysis

All data were analyzed using SPSS software (SPSS ver.21.0, Chicago USA). Fit to the expectation of Hardy-Weinberg Equilibrium (HWE) was tested using X2 test. For continuous variable, 1-sample Kolmogorov-Smirnov Test was conducted to check the normality of data distribution. Since the data were not distributed normally, the non-parametric analysis was performed. Mann-Whitney Test was performed to see the difference between alleles. The association between alleles and risk factors were analyzed using Spearman’s Test. P-value was set as ≤ 0.05 for significant correlation and set based on a two-tailed test.

Results

General characteristics of the study population

Four hundred and thirty-four subjects were included in the analysis. The characteristic in this study were presented in Table 1. The mean age of the sample population was homogenous between genders (range 14.8 years old to 16.1 years old).

Table 1: General Characteristic and metabolic syndrome prevalence in subjects.

Parameter(mean±SD) Total Male Female p-value
n=434 n=217 (50) n=217 (50)
Age (month) 177±4 177±4 177±4 0.180
Weight (kg) 50±10.1 52.2±10.6 47.7±9.1 0.000*
Height (cm) 159.8±7.7 164.4±6.9 155.2±5.3 0.000*
Waist Cir. (cm) 67.5±8 67.5±8 67.4±8 0.850
BMI (kg/cm2) 19.5±3.3 19.2±3.2 19.8±3.3 0.031*
Sistole (mmHg) 106±62 110±9 102±8 0.000*
Diastole (mmHg) 62±6 62±6 61±6 0.275
Cholesterol (mg/dL) 138.4±29.5 132±27 144±31 0.000*
LDL-C (mg/dL) 75.5±19.4 72±18 79±20 0.001*
HDL-C (mg/dL) 39±12 39±11 39±13 0.989
Triglyceride (mg/dL) 104±48 105±55 103±39 0.535
FBS (mg/dL) 91±9 93±9 89±8 0.000*
HbA1c (%) 5.5±0.8 5.6±0.8 5.4±0.7 0.056
IL-6 (pg/mL) 281.6±203 281±200 283±206 0.856
hs-CRP (mg/L) 0.7±1.6 0.8±1.69 0.7±1.58 0.221
TNF-α (pg/mL) 35.12±49.7 39.7±56.4 30.6±41.5 0.424
MetS Risk Factors n (%)  
MetS, N(%) 17 (3.9) 10 (4.6) 7(3.2)
Waist Circumference 43 (9,9) 22 (10,1) 21 (9,68)
Fasting Blood Sugar 59 (13,6) 39 (18) 20 (9,22)
HDL-Cholesterol 233 (53,7) 114 (52,5) 119 (54,8)
Triglyceride 61 (14,1) 33 (15,2) 28 (12,9)
Hypertension 3 (0,69) 3 (1,38) 0 (0)
Without Risk Factor 159 (36,6) 76 (35) 83 (38,2)

p < 0.05 is considered to be statistically significant.

Genotype and Allele Frequency Distribution of ABCG1 Polymorphism

Frequencies of ABCG1 genotypes in subjects did not deviate from Hardy Weinberg equilibrium (HWE) (p > 0.05). There is a small difference in allele frequency between gender. However, the allele frequency in the present study were similar with data in previous studies19 (Table 2).

Table 2: Genotype and allele distribution of ABCG1 between subjects.

Genotype Total Male Female
n=434 n= 217 n=217
AA (n/%) 104  (24) 51 (49.0) 53 (51)
AG (n/%) 229  (52,8) 121 (52.8) 108 (47.2)
GG (n/%) 101  (23,7) 45 (44.6) 56 (55.4)
G allele frequency 0.50 0.51 0.49
HWE p value 0.249 0.087 0.948

HWE p value; Hardy Weinberg equilibrium p-value; HWE p-value, for comparison among genotype in group; p-value for the comparison of genotype frequencies in male and female. *Based on the results of the chi-square test, p < 0.05 was considered statistically significant.

The proportion of wild allele and variant allele in each metabolic risk factor

The proportion of wild genotype (AA) and variant genotypes (AG+GG) in each criterion of MetS were showed in Table 3. All data show a similar trend that the frequency of having a criterion of Mets was increased in wild alleles by odd ratio analysis. However, no significant were observed.  This table shows that most of the subjects that meet the criteria, had wild alleles, in males and females’ groups. Contrary to that, the frequency of female subject who has higher waist circumference found in variant allele. Another interesting point can be highlighted is the percentage of subject with low HDL-c. It appears consistent that more than 50% of the subject in all gender and genotype has lower HDL.

Table 3: The proportion of wild genotype and variant genotypes in each MetS Criteria.

MetS Risk Factors Wild genotype(AA)(n/%) Variant genotype (AG+GG)(n/%) Odd ratio  (95% CI) P-value
        Male                                    51 (23.5)                        166 (76.5)
High Waist Cir. 7 (12.7) 15 (9.0) 1.602 (0.61-4.17) 0.425
High FBS 11 (21.6) 28(16.9) 1.355 (0.62-2.96) 0.532
Low HDL-C 27 (52.9) 87 (52.4) 1.022 (0.55-1.92) 1.000
High Triglyceride 8 (15.7) 25 (15.1) 1.049 (0.44-2.50) 1.000
Hypertension 0 (0) 3 (1.8) a) 1.000
       Female                                 53 (24.8)                        161 (75.2)
High Waist Cir. 3 (5.7) 18 (11) 0.487 (0.13-1.72) 0.422
High FBS 7 (13.2) 13 (7.9) 1.768 (0.67-4.70) 0.276
Low HDL-C 30 (56.6) 89 (54.3) 1.099 (0.59-2.05) 0.874
High Triglyceride 9 (17.0) 19 (11.6) 1.561 (0.66-3.70) 0.347
Hypertension 0 (0) 0 (0) a) 1.000

a) Test cannot be performed on empty group, *p < 0.05 is considered to be statistically significant.

Association of ABCG1 polymorphism with the metabolic syndrome (MetS) risk factors among control adolescents

When analyzed the subjects only who were not yet MetS case and cardio-metabolic risk factor or MetS components, there was a trend of higher inflammatory marker in variant genotypes. IL-6 levels were higher in variant genotypes compared to the wild genotypes in both genders. However, this result was considered significant only in the male group (p-value = 0.036), but not in the female group. FBS seems to be significantly higher in female groups for subjects who posed the variant genotypes (p value = 0.003) (Table 4).

Table 4: Correlation between the genotype with the MetS risk factor and inflammatory markers in healthy adolescent.

Parameter Wild genotype(AA) Variant genotype (AG+GG) p-value genotype
Male
Waist circumference (cm) 63.74±4.5 65.17±3.7 NS
Systole (mmHg) 109±8 110±9 NS
Diastole (mmHg) 61±7 62±6 NS
FBS (mg/dL)            89.81±3.9 88.83±5.8 NS
Triglyceride (mg/dL) 75.8±22.7 84.9±24.3 NS
Total cholesterol 142.2±32.8 134.3±23.6 NS
HDL-C (mg/dL) 49.5±7.4 48.0±6.7 NS
LDL 74.4±20.4 68.5±15.7 NS
IL-6 (pg/mL) 196.0±227.8 293.9±202.7 0.037
hCRP 0.37±0.7 0.65±1.6 NS
Female
Waist circumference (cm) 64.81±3.7 64.81±4.5 NS
Systole (mmHg) 102±8 102.8 NS
Diastole (mmHg) 61±5 61±6 NS
FBS (mg/dL) 85.0±4.6 88.9±5.4 0.003
Triglyceride (mg/dL) 83.8±25.6 80.9±19.1 NS
Total cholesterol 153.7±26.2 156.0±29.5 NS
HDL-C (mg/dL) 51.5±12.9 49.5±8.8 NS
LDL 77.6±19.2 81.2±20.7 NS
IL-6 (pg/mL) 251.5±169.2 313.1±214.5 NS
hCRP 0.28±0.3 0.39±1.3 NS

NS = Not Significant, Data are presented as mean – SD. p < 0.05 is considered to be statistically significant. The p-value for genotype were calculated by Mann-Whitney Test.

Discussion

ABCG1 is a cholesterol transporter that is known as the inducer of nascent HDL lipidation of and issues commands for redistribution of cholesterol to the outer of plasma membrane that facilitated by HDL. Some of the polymorphism of ABCG1 indicated a significant role in HDL metabolism20, and an association with the plasma Lipoprotein Lipase (LPL) which also functions in lipid deposit in macrophage.8

The polymorphism of ABCGI rs1044317 is located in the 3’-untranslated regions (UTR) of the chromosome 21.p12. Research regarding this gene has been conducted among some sample populations. Based on the result of this study, there was no correlation in general between the diagnosed of MetS with ABCG1 SNP rs1044317 even though the prevalence of the MetS case was match with the previous study which is 4% in adolescent population.3

The recent study showed that this SNP had no correlation with any plasma lipid profile (HDL-c, LDL-c, TG, TC) in the adolescent sample population, even though the adjustment model for gender and specific MetS criteria has been applied. In comparison with previous study held in Spanish Caucasian, the result is coherent. That population showed no significant effect between the Rs1044317 with any postprandial lipid level.21 In accordance with that, a study in Chinese Han population also concluded deleterious role of this SNP in the risk of any factors related to coronary artery disease.11 Meanwhile, one research was found conflicting with the recent result. It suggested the association between the rs1044317 with the fasting HDL-c level in subject with intake polyunsaturated fatty acid more than 13.6 g/day.22

ABCG1 in conjunction equally with ABCA1 participated to maintain glucose by controlling the secretion and activity of insulin.23 This is supporting the recent finding about hyperglycemia in female group with variant allele. In one animal study conducted in mice, ABCG1 expression is reduced in later stages of disease similar to beta cell failure which arises after hyperglycemia. This effect generated a positive feedback cycle which causes metabolic dysfunction.10 This idea supported by a coherence finding that suggested the Loss of beta cell ABCA1 and ABCG1 aggravate glucose intolerance and the dysfunction of b-cell.9 However, the pathway of downregulation of ABCG1 expression and its SNP by hyperglycemia stage is remain obscure.

Our research suggested that the healthy subjects with variant allele of rs1044317 tend to have a higher degree of inflammation based on the IL-6 level.24 This finding indirectly indicated that this subject group was prone to a higher risk of MetS. Low-grade inflammation is characterized in obesity within all ages and correlated significantly with MetS.14 The study that uncovered this relationship is still limited and the mechanism between them is unclear.

Another interesting result of this recent study was more than half population in all gender and genotypes are prone to have low level of HDL. Younger populations have a tendency of a better lipid profile with an optimum reverse cholesterol transport mechanism. Contrary with that, the low physical exercise and hypercaloric eating habit can lead to low HDL-c. Exercise, especially aerobic becomes an important factor to trigger the activation of PPAR that involved in reverse cholesterol transport. The product of this pathway is mature HDL-c.25 The current generation of Thai adolescent shifted the lifestyle from physically active to sedentary behavior.26 That explained the finding of low HDL-c in this study.

Currently, this research is the first of a kind in Thailand about ABCG1 SNP rs1044317 conducted in adolescent population. This study is expected to initiate the future research about this topic in Asian population. However, it was limited in several ways especially the study design and the number of subjects participated. Due to the sample population came from one province, the result might be recondite and did not represent the general effect in Thailand population.

This study detected the higher risk of MetS as the effect of rs1044317 in the variant allele. However, that result was only relevant in healthy subject. ABCG1 expression has been found enhance the cholesterol efflux interrelated with ABCA1 performance and other supportive agent27 and found significantly lower in MetS case.28 To explain this finding, future study should be undertaken to explore the expression of ABCG1-dependent agent and its pathway, with some SNPs, in variation of many age levels.

Conclusion

Returning to the question posed at the beginning of this study, the findings provide a result that the existence of RS1044317 ABCG1 SNP affected the susceptibility of specific criteria of MetS in Thai adolescence population. However, the correlation appeared significant after modification in gender and MetS related health factors. The subject who possesses the variance allele seems to have a higher risk of MetS. It was shown by the hyperglycemia in the females’ group and significant higher level of IL-6 in males’ group.

Authors’ contribution

LMGBS, TP, and CC participated in investigation. LMGBS wrote the original draft of manuscript. UT, NO, KT, and PL performed data analysis and CC reviewed and edited the final draft of the manuscript. All authors provided clarification and guidance on the manuscript. All authors were involved in editing the manuscript and approved the final manuscript.

Acknowledgement

The authors would like to thank all subjects and Institute of Nutrition, Mahidol University.

Conflict of Interest

The authors declare that they have no competing interests.

Funding Sources

No funding was supported this study.

Reference

  1. World Health Organization. South-East Asia regional parliamentarian’s meeting: a renewed commitment to women’s, children’s and adolescent’s health. World Health Organization. Regional Office for South-East Asia; 2019.
  2. Winichagoon P. Thailand nutrition in transition: situation and challenges of maternal and child nutrition. Asia Pacific journal of clinical nutrition. 2013 Jan;22(1):6-15.
  3. Rerksuppaphol L, Rerksuppaphol S. Prevalence of metabolic syndrome in Thai children: a cross-sectional study. Journal of clinical and diagnostic research: JCDR. 2014 Apr;8(4):PC04.
  4. Messiah SE, Arheart KL, Lopez‐Mitnik G, Lipshultz SE, Miller TL. Ethnic group differences in cardiometabolic disease risk factors independent of body mass index among American youth. Obesity. 2013 Mar;21(3):424-8.
  5. Jago R, Harrell JS, McMurray RG, Edelstein S, El Ghormli L, Bassin S. Prevalence of abnormal lipid and blood pressure values among an ethnically diverse population of eighth-grade adolescents and screening implications. Pediatrics. 2006 Jun 1;117(6):2065-73.
  6. Stančáková A, Laakso M. Genetics of metabolic syndrome. Reviews in Endocrine and Metabolic Disorders. 2014 Dec;15(4):243-52.
  7. Hardy LM, Frisdal E, Le Goff W. Critical role of the human ATP-binding cassette G1 transporter in cardiometabolic diseases. International journal of molecular sciences. 2017 Sep;18(9):1892.
  8. Olivier M, Tanck MW, Out R, Villard EF, Lammers B, Bouchareychas L, Frisdal E, Superville A, Van Berkel T, Kastelein JJ, Eck MV. Human ATP–binding cassette G1 controls macrophage lipoprotein lipase bioavailability and promotes foam cell formation. Arteriosclerosis, thrombosis, and vascular biology. 2012 Sep;32(9):2223-31.
  9. Kruit JK, Wijesekara N, Westwell-Roper C, Vanmierlo T, De Haan W, Bhattacharjee A, Tang R, Wellington CL, LütJohann D, Johnson JD, Brunham LR. Loss of both ABCA1 and ABCG1 results in increased disturbances in islet sterol homeostasis, inflammation, and impaired β-cell function. Diabetes. 2012 Mar 1;61(3):659-64.
  10. Sturek JM, Castle JD, Trace AP, Page LC, Castle AM, Evans-Molina C, Parks JS, Mirmira RG, Hedrick CC. An intracellular role for ABCG1-mediated cholesterol transport in the regulated secretory pathway of mouse pancreatic β cells. The Journal of clinical investigation. 2010 Jul 1;120(7):2575-89.
  11. Xu Y, Wang W, Zhang L, Qi LP, Li LY, Chen LF, Fang Q, Dang AM, Yan XW. A polymorphism in the ABCG1 promoter is functionally associated with coronary artery disease in a Chinese Han population. Atherosclerosis. 2011 Dec 1;219(2):648-54.
  12. González M, del Mar Bibiloni M, Pons A, Llompart I, Tur JA. Inflammatory markers and metabolic syndrome among adolescents. European journal of clinical nutrition. 2012 Oct;66(10):1141-5.
  13. Mohammadi M, Gozashti MH, Aghadavood M, Mehdizadeh MR, Hayatbakhsh MM. Clinical significance of serum IL-6 and TNF-α levels in patients with metabolic syndrome. Reports of biochemistry & molecular biology. 2017 Oct;6(1):74.
  14. Wärnberg J, Marcos A. Low-grade inflammation and the metabolic syndrome in children and adolescents. Current opinion in lipidology. 2008 Feb 1;19(1):11-5.
  15. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical chemistry. 1972 Jun 1;18(6):499-502.
  16. Tuntipopipat S, Muangnoi C, Chingsuwanrote P, Parengam M, Chantravisut P, Charoenkiatkul S, Svasti S. Anti-inflammatory activities of red curry paste extract on lipopolysaccharide-activated murine macrophage cell line. Nutrition. 2011 Apr 1;27(4):479-87.
  17. Wittcopp C, Conroy R. Metabolic Syndrome in Children and Adolescents. Pediatrics in review. 2016 May 1;37(5):193-202.
  18. Zimmet P, Alberti KG, Kaufman F, Tajima N, Silink M, Arslanian S, Wong G, Bennett P, Shaw J, Caprio S, IDF Consensus Group. The metabolic syndrome in children and adolescents–an IDF consensus report. Pediatric diabetes. 2007 Oct;8(5):299-306.
  19. The National Center for Biotechnology Information. [Internet]. SNP rs 1044317. [cited 2020 May 1]; Available from: https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?do_not_redirect&rs=rs1044317
  20. Zago VH, Scherrer DZ, Parra ES, Panzoldo NB, Alexandre F, Nakandakare ER, Quintão EC, de Faria EC. Association between ABCG1 polymorphism rs1893590 and high-density lipoprotein (HDL) in an asymptomatic Brazilian population. Molecular biology reports. 2015 Mar 1;42(3):745-54.
  21. Abellán R, Mansego ML, Martínez-Hervás S, Martín-Escudero JC, Carmena R, Real JT, Redon J, Castrodeza-Sanz JJ, Chaves FJ. Association of selected ABC gene family single nucleotide polymorphisms with postprandial lipoproteins: results from the population based Hortega study. Atherosclerosis. 2010 Jul 1;211(1):203-9.
  22. Abellán R, Mansego ML, Martínez-Hervás S, Morcillo S, Pineda-Alonso M, Carmena R, Real JT, Redon J, Rojo-Martínez G, Martín-Escudero JC, Chaves FJ. Dietary polyunsaturated fatty acids may increase plasma LDL-cholesterol and plasma cholesterol concentrations in carriers of an ABCG1 gene single nucleotide polymorphism: study in two Spanish populations. Atherosclerosis. 2011 Dec 1;219(2):900-6.
  23. Patel DC, Albrecht C, Pavitt D, Paul V, Pourreyron C, Newman SP, Godsland IF, Valabhji J, Johnston DG. Type 2 diabetes is associated with reduced ATP-binding cassette transporter A1 gene expression, protein and function. PLoS One. 2011 Jul 27;6(7):e22142.
  24. El-Byoumy I. Interleukin 6 as inflammatory marker and insulin resistance in obese Kuwaiti adolescents. Integr Obes Diabetes. 2017;3(3):1-3.
    CrossRef
  25. Marques LR, Diniz TA, Antunes BM, Rossi FE, Caperuto EC, Lira FS, Gonçalves DC. Reverse cholesterol transport: molecular mechanisms and the non-medical approach to enhance HDL cholesterol. Frontiers in Physiology. 2018 May 15;9:526.
  26. Liangruenrom N, Suttikasem K, Craike M, Bennie JA, Biddle SJ, Pedisic Z. Physical activity and sedentary behaviour research in Thailand: a systematic scoping review. BMC Public Health. 2018 Dec;18(1):1-24.
  27. Liao S, McLachlan CS. Cholesterol efflux: does it contribute to aortic stiffening?. Journal of cardiovascular development and disease. 2018 Jun;5(2):23.
  28. Tavoosi Z, Moradi-Sardareh H, Saidijam M, Yadegarazari R, Borzuei S, Soltanian A, Goodarzi MT. Cholesterol transporters ABCA1 and ABCG1 gene expression in peripheral blood mononuclear cells in patients with metabolic syndrome. Cholesterol. 2015;2015.

List of abbreviation

MetS      = Metabolic syndrome

WC        = Waist circumference

TG          = Triglyceride

HDL-c   = High-Density Lipoprotein-cholesterol

BP          = Blood pressure

FBS        = Fasting blood sugar

ABCG1 = ATP Binding Cassette G member 1

SNP        = Single nucleotide polymorphism

TC          = Total cholesterol

LDL-c    = Low-Density Lipoprotein-cholesterol

HPLC     = high-performance liquid chromatography

IL-6        = Interleukin-6

TNF-   = Tumor Necrotic Factor-

ELISA    = Enzyme-Linked Immunosorbent Assay

hs-CRP  = high sensitivity C-Reactive Protein

HWE      = Hardy-Weinberg Equilibrium

LPL        = Lipoprotein Lipase

PPAR     = Peroxisome proliferator-activated receptor


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.